How Swiss medtech firms can benefit from a U.S. tariff exemption

Medical technology exporters from Switzerland and Liechtenstein face increasing challenges due to shifting U.S. customs regulations and rising tariffs. One lesser-known solution offers significant relief: the tariff exemption under the Nairobi Protocol.

How the Nairobi Protocol supports medtech exports

This international trade law, implemented in the United States since 1982, allows duty-free importation of medical devices and patient care solutions that are specially designed for individuals with chronic or permanent disabilities. Qualifying products include items like glucose monitors, pacemakers or mobility aids. For companies seeking market access to the United States, this provision reduces export barriers and supports a cost-efficient entry strategy. To benefit, companies must demonstrate that their product is tailored for a defined health condition and offers utility beyond general use. U.S. Customs and Border Protection applies a five-point assessment to determine eligibility. While self-declaration is possible, obtaining a formal customs ruling increases legal certainty and minimizes trade compliance risks.

A strategic advantage in a high-tariff environment

In a climate of escalating duties, utilizing this tariff exemption can boost competitiveness and improve supply chain economics for medtech and health tech firms. Yet many exporters remain unaware of its potential. Understanding the exact regulatory scope, including what qualifies and what is excluded, is key to unlocking this opportunity. This report delivers expert insights on customs optimization for medical technology firms, including practical guidance on product classification, regulatory criteria, and how to request a binding decision from U.S. authorities. Swiss and Liechtenstein companies can leverage this underused exemption to enter the U.S. market more efficiently and competitively. Download the full report now to access detailed legal insights and concrete case examples for smarter U.S. market access.